Cansino (688185.SH): DTCP-HIB-MCv4 combination vaccine clinical trial application approved

Zhitongcaijing · 02/24 08:41

Zhitong Finance App News, Cansino (688185.SH) issued an announcement. The company recently received the approval and issuance of the “Drug Clinical Trial Approval Notice” for adsorption of acell-free 100 (component) haemophilus albicans (conjugated) -ACYW135 meningococcus (conjugate) vaccine (“DTCP-HIB-MCv4 combination vaccine” for short).